Posts for Ticker ‘DVA’

Top Pre-Market Analyst Upgrades (BBY, CB, DVA, DFT, FCX, FMS, MWE, MCHP, WFT)

Money_stack_picThese are some of the top per-market analyst upgrades and positive calls we are seeing from Wall Street this Thursday morning:

  • Best Buy (BBY) Raised to Overweight at Barclays.
  • Chubb (CB) Raised to Buy at Bank of America-Merrill Lynch.
  • DaVita (DVA) Started as Outperform at RBC.
  • Dupont Fabros Tech (DFT) Raised to Buy at UBS.
  • Freeport McMorRan (FCX) Raised to Hold at Canccord.
  • Fresenius Medical (FMS) Started as Outperform at RBC.
  • MarkWest Energy (MWE) Raised to Outperform at Morgan Keegan.
  • Microchip Tech (MCHP) Raised to Overweight at Barclays.
  • Weatherford (WFT) Raised to Overweight at JPMorgan.

Jon C. Ogg
January 29, 2009

Posted on: January 29, 2009 – 7:48 am in Analyst Calls, , , , , , , , ,

Top 10 Pre-Market Analyst Calls (AIV, BBBY, DVA, LEH, MCD, OPLK, PERY, HOT, TLAB, WLP)

These are the top analyst calls we are looking at this Friday morning:

  • Apartment Investment (NYSE: AIV) Cut To Neutral From Buy at UBS.
  • Bed Bath & Beyond (NASDAQ: BBBY) Cut To Underweight from Neutral at JPMorgan.
  • Davita (NYSE: DVA) Raised To Buy From Neutral at UBS.
  • Lehman Brothers (NYSE: LEH) Raised To Buy From Hold at Citigroup.
  • McDonald’s (NYSE: MCD) Started At Overweight at Morgan Stanley.
  • Oplink Communications (NASDAQ: OPLK) Cut To Sell From Neutral at Piper Jaffray.
  • Perry Ellis (NASDAQ: PERY) Started At Buy at SunTrust.
  • Starwood Hotels (NYSE: HOT) Cut To Market Perform from Outperform at Wachovia.
  • Tellabs (NASDAQ: TLAB) Cut To Neutral From Buy at UBS.
  • WellPoint (NYSE: WLP) Cut To Equal-weight From Overweight at Lehman.

Jon C. Ogg
March 28, 2008

Posted on: March 28, 2008 – 6:54 am in Analyst Calls, , , , , , , , , ,

Microcap Featured in Dialysis Investing (XCR, NXTM, DVA, FMS, DCAI)

Xcorporeal, Inc. (AMEX: XCR) is a potential undiscovered gem in microcap and low-priced stock investing, and it is in the arena of kidney dialysis.  This week’s "INSIDE WALL STREET" segment in Business Week featured this stock, and this may be their most unusual pick in months with perhaps the greatest upside potential if it can live up to the hopes and plans.

This one has been under review for our "10 Stocks Under $10" weekly letter, although we have not yet added it to the list because of its performance and lack of history.  Xcorporeal first came to us after it’s Wearable Artificial Kidney (WAK) prototype device was featured in the December 15, 2007 journal issue of The Lancet, an influential medical journal.

It is entering a space dominated by public companies such as DaVita Inc. (NYSE: DVA), Dialysis Corp. of America (NASDAQ: DCAI), Fresenius Medical Care AG & Co. KGaA (NYSE: FMS), and Nxstage Medical, Inc. (NASDAQ: NXTM). Of the public dialysis companies, this is also the most risky stock of the ones we have reviewed in the dialysis companies.

Read More »

Posted on: March 14, 2008 – 7:21 am in Medical, , , , ,

Top 10 Pre-Market Analyst Calls (ADBE, CRUS, DVA, EEQ, EQR, IP, LNCR, RGLD, WIN, BRL, MFLX, MYL, TEVA, WPI)

These are not the only analyst impact calls, but these are the top research notes that 247WallSt.com is focusing on:

  • Adobe Systems (ADBE) raised to Buy at Deutsche Bank.
  • Cirrus Logic (CRUS) raised to Buy at Jefferies.
  • DaVita (DVA) raised to Buy at Oppenheimer.
  • Embarq (EQ) raised to Overweight at J.P.Morgan.
  • Equity Residential (EQR) raised to Overweight at Lehman.
  • International Paper (IP) raised to Outperform at Credit Suisse.
  • Lincare (LNCR) downgraded to Neutral at Oppenheimer.
  • Royal Gold (RGLD) raised to Overweight at HSBC.
  • Windstream (WIN) downgraded to Underweight at J.P.Morgan.
  • BANC OF AMERICA ON DRUGS: Barr Pharma (BRL) started as Buy; Multi-Fineline (MFLX) started as Buy; Mylan Labs (MYL) started as Buy; Teva Pharma (TEVA) started as Buy; Watson Pharma (WPI) started as neutral; ZymoGenetics (ZGEN) downgraded to Neutral.

Jon C. Ogg
December 18, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.

Posted on: December 18, 2007 – 7:59 am in Analyst Calls, , , , , , , , , , , , , ,

Pre-Market Analyst Calls (September 4, 2007)

ABY raised to Neutral at UBS.
AMD raised to neutral at Credit Suisse.
AG raised to neutral at Credit Suisse.
AEO raised to Outperform at Cowen.
BLOG started as Outperform at Wachovia.
DVA raised to Buy at Deutsche Bank.
EXEL cut to Mkt Perform at Wachovia.
FCSX raised to BUy at B of A.
HOKU raised to Mkt Perform at Piper Jaffray.
HSII cut to Sell at UBS.
INFA started as Outperform at CIBC.
KFN cut to Sell at UBS.
KOP cut to Hold at Jefferies.
KPN cut to Hold at Citigroup.
KSU raised to Buy at UBS.
MNST cut to Neutral at UBS.
MXIM started as Outperform at RBC Capital.
OII started as Overweight at JPMorgan.
OTE cut to Peer Perform at Bear Stearns.
PCG raised to Overweight at Lehman.
RDS/A raised to Buy at UBS.
RHI cut to Neutral at UBS.
RIMM cut to Peeer Perform at Bear Stearns.
SMOD cut to Hold at Citigroup.
SPR started as Overweight at Lehman.
TEF cut to Hold at Citigroup.
TMA raised to Outperform at FBR.
TYC raised to Buy at Deutsche Bank.
TYPE started as Buy at B of A.
TYPE started as Buy at Jefferies.
WEC raised to Overweight at Lehman.

Jon C. Ogg
September 4, 2007

Posted on: September 4, 2007 – 7:12 am in Analyst Calls, , , , , , , , , , , , , , , , , , , ,